tirzepatide phase 2 obesity Presented at ECO 2025: In the SURMOUNT-5 3b trial involving adults with without type diabetes, was superior to semaglutide in reducing body weight and waist circumference. Full trial Tirzepatide did not impact metabolic
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


















/assets/production/practices/dffa88faf9887b01856b18477151f6b695f51a4e/images/2751963.jpg)






